Relapsing polychondritis(RP) is extremely rare, affecting 3 to 5 people per million. Here is a collection of peer-reviewed articles and an overview of current RP research to help healthcare professionals better understand this disease.
Doctors discuss a patient’s initial symptoms, lab tests, relapsing polychondritis diagnosis, treatment plan, and outcomes.
Researchers provide a comprehensive look into clinical presentation, laboratory and instrumental investigations, diagnostic criteria, and therapeutic options for RP.
Researchers present a systematic review of clinical practice guidelines published for RP, as well as a list of the unmet needs for this rare disease.
Researchers review the current state of RP management, with a focus on the use of the anti-TNF-α agents in patients with pulmonary involvement.
Through the synergy of our partnerships, we’re reimagining RP-centered research and patient care. We’re always looking for innovative partners and targeted collaborative opportunities that drive real results for patients and families living with RP and other autoimmune diseases.
Until recently, there were few options and even fewer resources for patients living with RP. We’re working every day to unlock the mysteries of RP and deliver hope to patients and their families.